Monopolar and Bipolar in Esophageal ESD
Study Details
Study Description
Brief Summary
The objective of this study is to prospectively document the efficacy and clinical outcomes of Endoscopic Submucosal Dissection procedure that utilize either the novel Bipolar-Current ESD device (Speedboat RS2 by Creo Medical) or a monopolar knife.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Endoscopic submucosal dissection (ESD) is a novel technique for the removal of esophageal lesions or polyps with high-risk features. ESD is minimally invasive and allows the removal of esophageal polyps without resorting to morbid surgery. The process of ESD includes marking the lesions selected for removal, followed by submucosal injection of a lifting agent, then circumferential incisions using a specialized knife followed by submucosal dissection of the entire lesion.
Traditionally, knifes utilizing monopolar current such as dual knife or hybrid knife were the preferred tools for endoscopic submucosal dissection. These knifes allows accurate dissection and excellent hemostasis. However, due to monopolar current generated heat, post coagulation syndrome can be seen in up to 8 to 40 % of patients. Post coagulation syndrome present with pain, fever and leukocytosis and requires supportive treatment with IV fluid and antibiotics. In addition, for large esophageal lesions, stricturing can occur after resection due to significant scar formation induced by large amounts of energy. Almost all patients with 60% of the esophageal circumference removed via monopolar knives, will develop an esophageal stricture at some point. These patients require serial esophageal dilations, and although easily managed, its development can be quite troublesome to the patient. Nevertheless, ESD is still the preferred modality for removal of these lesions, since it avoids the need for morbid surgery. Recently, a novel bipolar RFA knife were approved by FDA for the performance of ESD. The knife utilizes bipolar RFA current for submucosal dissection which can potentially expedite submucosal dissection and decrease the rates of post polypectomy syndrome and scar formation, by using significantly less energy. This bipolar knife may allow for removal of large esophageal lesions without causing major esophageal stricturing.
Our tertiary referral center Baylor St Luke's Medical Center is a center of excellence for ESD procedure and we have previously reported our Esophageal ESD experience using the monopolar current knife. The goal of our protocol is to compare the performance of monopolar current cutting knife and bipolar RFA knife in esophageal endoscopic submucosal dissection.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Monopolar Electrocautery tool Patients randomized into this group will receive the standard of care monopolar tool for their POEM procedure. |
Procedure: Endoscopic Submucosal Dissection
Use of Monopolar electrocautery knife to perform the Endoscopic Submucosal Dissection in the esophagus
Other Names:
|
| Experimental: Bipolar Electrocautery tool Patients randomized into this group will receive the standard of care bipolar tool for their POEM procedure. |
Procedure: Endoscopic Submucosal Dissection
Use of Monopolar electrocautery knife to perform the Endoscopic Submucosal Dissection in the esophagus
Other Names:
Device: Speedboat (Bipolar electrocautery knife)
Use of Creo Medical's Speedboat RS2 knife and generator in performing the ESD procedure for patients with required esophageal lesion removal.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Speed of Endoscopic Submucosal Dissection [Day 1 (procedure day)]
The speed of endoscopic submucosal dissection as calculated by cm2/hour
Secondary Outcome Measures
- En-bloc resection achieved [Day 1 (procedure day)]
Endoscopist removal of entire tissue specimen as a whole
- R0 Resection achieved [1-3 days post-procedure]
Margins of tissue specimen deemed by pathologist as completely excised (R0)
- Curative Resection achieved [1-3 days post-procedure]
Complete removal of diseased tissue by endoscopic submucosal dissection procedure
- Adverse events [1 month, 3 months, 6 months, 12 months]
Collection of unanticipated medical occurrences within a 12 month time frame
- Rate of esophageal stricturing post-procedure [1-3 days post-procedure]
Calculated as a percentage of patients reported with stricturing with 1-3 days following procedure.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient is ≥ 18 years old
-
Patient is capable of providing informed consent
-
Patient is referred for ESD procedure of an esophageal neoplastic lesion
Exclusion Criteria:
-
Patient is < 18 years old
-
Patient refused and/or unable to provide consent
-
Patient is a pregnant woman
-
Patients with lesions removed with other techniques besides ESD (i.e. cap EMR) or a modified ESD technique
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Baylor College of Medicine | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- Baylor College of Medicine
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- H-52921